Medical Data Articles & Analysis

Anonymized medical data sharing is necessary for the advancement of medicine, but it requires a tremendous amount of trust from all stakeholders. Patients need to trust that their healthcare providers are utilizing their data to advance innovations that will help them in the future. Healthcare providers such as health systems and hospitals must trust external stakeholders to use that data for ...

By Segmed, Inc.

We are now gaining an understanding of the impact of this global pandemic. Infection rate drives the need for better data collection, analysis and reporting in real-time. Addressing contamination control for our healthcare facilities becomes ground zero in preventing and controlling an outbreak. In their efforts to fight the pandemic and contain its spread, Novatek Medical Data Systems has ...

By Novatek Medical Data Systems

ATsens developed the first wearable long-term continuous ECG monitor in Korea. Honorary professor Lee Man-Yeong was appointed as CMO and head of the data center for medical advice and data center establishment. He’s a professor of Circulatory Internal Medicine and an authority in the field of arrhythmia, who continued research and treatment of arrhythmia during his tenure. Participate ...

By ATsens Co., Ltd.

With the number of medical research papers published daily, we know it’s challenging to stay up-to-date. We strongly believe that the way medical scientific data reaches professionals needs a change: quick, transparent, and available wherever you are. SURUS is at your disposal to help finding your way through the world of medical scientific information, in order to make independent ...

By Medstone Holding BV

Heartbeat Medical, a leading provider of digital medical devices in the field of Patient-Reported Outcomes (PROs), announced the appointment of Michael Erdtmann as Chief Commercial Officer. As part of the management team, Michael Erdtmann will be responsible for driving the growing new business as well as deepening existing partnerships and providing a bridge between the Medical Devices and Life ...

By Heartbeat Medical

Procyrion, Inc., a medical device company developing a catheter-deployed micropump for the management of chronic heart failure, today announced that its AortixTM device won the MedTech Breakthrough Award for "Best Overall Medical Device Product." MedTech Breakthrough is an independent organization that recognizes the top companies, technologies and products in the global health and medical ...

By Procyrion, Inc.

ConcertAI, LLC (ConcertAI), a leader in enterprise AI and RWD solutions for life science companies and healthcare providers, announced today the integration of TeraRecon as a ConcertAI company. The combination is unprecedented in bringing electronic medical records, genomic data, and medical image data into one integrated network and set of AI-enabled workflows that enable leading ...

By TeraRecon, Inc.

xCures, a Real-Time Regulatory Grade Clinical Data (RRC) platform, will be joining Aetion, a global real-world evidence software and analytics provider, and a group of leading diverse partners in Aetion’s launch of the Coalition for the Advancement of RWE through Randomized Controlled Trial Emulation (CARE) Initiative. Aetion’s initiative will focus on better understanding the ...

By xCures

GALAXY’S PROPRIETARY CENTAURI™ SYSTEM ON TRACK FOR EU REGISTRATION AND US PIVOTAL TRIAL START LATER THIS YEAR; SHOWS BEST-IN-CLASS POTENTIAL. SAN CARLOS, California, March 16, 2021 — ATP, a leader in life science venture capital, announced today $18M in Series A financing for its portfolio company Galaxy Medical, Inc. The funds are being used to advance the development of ...

By Galaxy Medical

xCures, Inc. is proud to announce their collaboration with mProbe Inc., a premier CLIA-certified targeted proteomics company. mProbe utilizes a proprietary technology platform integrating artificial intelligence and multi-omic diagnostics to transform the diagnosis, prevention, and treatment of complex diseases such as cancer. As the knowledge of cancer and its treatments advance, it is ever ...

By xCures

Key data highlights with the Evoke® System to include holistic composite treatment outcomes for disrupting the chronic pain cycle; opioid-sparing effects of therapy; real-world results; and cost-effectiveness compared to open-loop stimulation. Saluda Medical Pty Limited (“Saluda Medical”), a global medical device company revolutionizing the field of neuromodulation with an ...

By Saluda Medical Pty Ltd.

The round, led by Omnes, Merieux Equity Partners, together with the Software Club and existing investors, Elaia and IRDI Capital Investissement, will enable SeqOne Genomics to accelerate its international sales and the development of new collaborative genomic analysis tools to facilitate communications between different disciplines in the medical team, in order to improve patient outcomes in ...

By SeqOne S.A.S.

While medical AI has many potential benefits, there are challenges that have not been tackled yet. One of the major challenges is the limited generalizability of many AI algorithms. Applying a medical AI algorithm that is trained in hospital A may give unexpected results when applied in hospital B. Why does this happen? Certain parameters are different between hospitals. If hospital A has Siemens ...

By Segmed, Inc.

CORK MEDTECH STARTUP AventaMed has joined a consortium of big-name healthcare companies for collaborations ahead of a planned US launch. AventaMed has developed a device for inserting grommets into the eardrum, which prevents the build up of fluid. The consortium – called the National Evaluation System for Health Technology Coordinating Center (NESTcc) – connects regulators and the ...

By AventaMed DAC

Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company focused on developing products to treat and transform the lives of patients suffering from venous and other diseases, announced positive outcomes of the fully enrolled 800-patient FLASH registry in pulmonary embolism (“PE”). The data was presented during a Late-Breaking Clinical Trial session at the 2022 ...

By Inari Medical

CARLSBAD, Calif.--(BUSINESS WIRE)--Carlsmed, Inc., announced today the U.S. launch of the aprevo® patient-specific spine technology and the New Technology Add-On Payment (NTAP) reimbursement. “We are grateful for our surgeon partners that worked with the company early on to develop a truly personalized solution for patients and to collect the clinical data for improved outcomes,” ...

By Carlsmed, Inc.

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced the results from data presentations at NANS supporting the use of HF10® therapy for patients with chronic pain, including results from the Painful Diabetic Neuropathy (PDN) and Non-Surgical Refractory Back Pain (NSRBP) randomized ...

By Nevro Corp.

Diamyd Medical will be a full voting member of the Type 1 Diabetes Consortium (T1DC) led by the US non-profit organization the Critical Path Institute (C-Path). The T1DC brings together diverse stakeholders from industry, academia and patient organizations to develop solutions to accelerate drug development for Type 1 Diabetes, including biomarker endpoints and model-informed drug development ...

By Diamyd Medical AB

Clinicians at Ardent’s BSA Hospital in Amarillo, Texas, began using the BioButton wearable device and BioCloud analytics engine in September to automate the collection of inpatient vital signs in general care units and increase both patient and clinician satisfaction. With plans for expansion across Ardent’s 30 hospitals, the program also leverages BioIntelliSense’s FDA-cleared ...

By BioIntelliSense, Inc.

Gyroscope Therapeutics Holdings plc (“Gyroscope”), a clinical-stage gene therapy company focused on diseases of the eye, announced positive interim data from the ongoing open-label Phase I/II FOCUS clinical trial of its investigational one-time gene therapy, GT005, in people with geographic atrophy (GA) secondary to age-related macular degeneration (AMD) were presented today in an ...

By Gyroscope Therapeutics Limited